Cytokinetics, Incorporated CYTK
$ 56.72
2.2%
Quarterly report 2024-Q2
added 08-09-2024
Country |
USA |
IPO year |
2004 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Robert Blum |
Employees in the company |
156 |
Shares |
96.5 K |
Market Cap[1] |
$ 5.47 M |
EBITDA (LTM) |
$ -314 M |
P/E (LTM) |
-10.37 |
P/S (LTM) |
0.88 |
EPS (LTM) |
-5.38 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.